Tecentriq 1,200 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DX25F6ABR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $26,012
Award facts
- Contract value 100% obligated
- $26,011.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $26,011.96 for 1,200 mg/20 ml vials of Tecentriq on July 21, 2025. The contract, which carries an ultimate completion date of August 11, 2025, was issued without a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's SPE2DB program, a $499,999,999 master contract valid through November 2026 that authorizes the issuance of firm fixed-price delivery orders for pharmaceutical products supporting Department of Defense healthcare facilities.
Tecentriq, an oncology treatment, represents one of many specialized pharmaceutical products DMS Pharmaceutical Group supplies to federal military and healthcare systems nationwide. The award demonstrates the company's established role as a critical supplier within the federal pharmaceutical supply chain, leveraging its status as a woman-owned small business to compete effectively in federal procurement. The Medical Supply Chain organization, operating under the Defense agency classification, utilized this delivery order mechanism to procure the medication for distribution to military health facilities, continuing the company's pattern of supporting Department of Defense healthcare logistics requirements.
Quick answers
Who was awarded contract SPE2DX25F6ABR?
SPE2DX25F6ABR was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 21, 2025.
How much is contract SPE2DX25F6ABR worth?
The government has obligated $26,012 on SPE2DX25F6ABR.
Is contract SPE2DX25F6ABR an order under another contract?
Yes. SPE2DX25F6ABR is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6ABR competed?
The extent of competition for SPE2DX25F6ABR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award